![](https://www.newswise.com/assets/new/img/newswise-logo-square.jpg)
Nasal COVID-19 Vaccine Based on WashU Technology to Enter U.S. Clinical Trials
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug application from Ocugen, Inc. was approved by the Food and Drug …